The unsettling experience of facing a major surgery is fraught with enough anxiety without the added shock of an insurance denial arriving days before a scheduled procedure. But for Ron Lieber, a personal finance columnist for the New York Times, and his wife, Jodi Kantor, a celebrated journalist herself, this became a stark reality in December 2024. Their story, initially unfolding as a personal crisis, quickly illuminated a systemic problem: the increasingly common, and often opaque, practice of prior authorization, and the sheer difficulty patients face navigating a healthcare system seemingly designed to create obstacles. What’s particularly striking isn’t just the denial itself, but the timing – delivered with insufficient notice – and the realization that this wasn’t an isolated incident, but a widespread phenomenon impacting millions.
Lieber’s initial reaction wasn’t simply frustration, but a professional embarrassment. As someone whose career centers on helping people navigate complex financial systems, he felt a pang of recognition akin to the lead-up to the 2008 financial crisis – a sense of having missed something crucial. “I had that same feeling that I did in 2008,” he recounted in a recent interview on the podcast An Arm and a Leg. “Back in 2008. It was, you know, Ron, why did you not become an expert on mortgage securitization before now?” This time, the looming expertise gap was in the realm of prior authorization, a process requiring insurers to approve certain procedures before they’re performed. The denial, a partial one affecting the mastectomy portion of Kantor’s breast cancer surgery, felt particularly absurd. The reconstructive surgery was approved, creating a baffling and deeply unsettling disconnect.
The situation quickly escalated beyond a simple insurance dispute. While Lieber possessed the resources – a robust employer with experienced HR personnel, access to top-tier legal counsel through the New York Times, and a hospital accustomed to battling insurance companies – he recognized the inherent power imbalance. Memorial Sloan Kettering, he reasoned, likely had dedicated staff to handle these issues, but the average patient wouldn’t have that advantage. He was determined to fight the denial, not just for his wife, but as a matter of principle. Crucially, Lieber made a conscious decision not to leverage his position at the New York Times to expedite the process, adhering to the newspaper’s strict ethical code. This commitment to fairness, while adding a layer of complexity, underscored his desire to understand the experience from the perspective of an ordinary patient.
This piece references the kffhealthnews.org report.
However, the timing of the ordeal coincided with a disturbing national event: the shooting of Brian Thompson, the CEO of UnitedHealthcare, allegedly by an individual motivated by frustrations with the insurance company’s denial practices. Shell casings found at the scene bore the words “deny, defend, depose,” a chilling indication of the anger fueling the attack. While Lieber was navigating his own crisis, the broader context highlighted the potential for escalating desperation and violence stemming from healthcare access issues. The coincidence, as Lieber described it, was surreal: “People are like, oh, is he still on the loose? They just, just couldn’t believe that like this thing, you know, that Luigi was clearly upset about, right, was presenting itself in real time while he was still being chased.”
Ultimately, Kantor’s surgery proceeded as scheduled, and the denial was quietly resolved after Lieber persistently engaged with the hospital’s billing department. The resolution, however, came with a frustrating revelation: the hospital had been aware of the denial for seven to eight days, but hadn’t proactively informed the couple. This lack of communication, Lieber argues, is a critical flaw in the system. His subsequent reporting in the New York Times led to hundreds of responses from readers sharing similar experiences, prompting him to develop a template for a doctor’s note designed to proactively inform patients about potential prior authorization hurdles. This template, refined through feedback from both patients and physicians, aims to mitigate the anxiety and disruption caused by last-minute denials.
It’s important to acknowledge the limitations of this story. Lieber’s experience, while representative of a broader trend, benefited from his resources and professional skills. The outcome might have been drastically different for someone without access to a large employer’s HR department or the ability to dedicate significant time to navigating the bureaucratic maze. Furthermore, the focus on UnitedHealthcare doesn’t necessarily indict the entire insurance industry; prior authorization issues are prevalent across multiple providers. The story also doesn’t offer a comprehensive solution to the problem of prior authorization itself, which remains a contentious issue with complex economic and political dimensions. The next crucial steps in research involve quantifying the true cost of prior authorization – not just in financial terms, but in terms of patient stress, delayed care, and potential health outcomes. We need to understand why these denials occur, and whether they genuinely improve healthcare quality or simply serve as a cost-containment measure. And, perhaps most importantly, we need to consider whether a system that requires patients to fight for access to necessary care is ethically justifiable in the first place. Will hospitals proactively adopt patient-facing communication strategies regarding prior authorization? That’s a development worth watching closely in the coming months.
